The role of red yeast rice for the physician

Current Atherosclerosis Reports

Volumn 13, Issue 1, 2011, Pages 73-80

  Gordon, Ram Y ^a,b,c   Becker, David J ^a,b  

^a Delaware Valley Nephrology and Hypertension   (United States)

^b ABINGTON MEMORIAL HOSPITAL   (United States)

^c NONE   (United States)

Author keywords

Alternative medications; Herbal medications; Hypercholesterolemia; Hyperlipidemia; Lipid lowering; Red yeast rice; Statin intolerance; Statin refusal; Statin associated myalgias; Supplements, complementary and alternative therapy

Indexed keywords

CHOLESTIN; FISH OIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCOL; LDL X; LIVER ENZYME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PLACEBO; PRAVASTATIN; RESQ 1250; SIMVASTATIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ALTERNATIVE MEDICINE; ANAPHYLAXIS; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CREATINE KINASE BLOOD LEVEL; DIET SUPPLEMENTATION; DIET THERAPY; DIZZINESS; DRUG CONTROL; DRUG EFFICACY; DRUG ERUPTION; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG MONITORING; DRUG POTENCY; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FERMENTED PRODUCT; FOOD AND DRUG ADMINISTRATION; FOOD COMPOSITION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; KINESIOTHERAPY; LIFESTYLE MODIFICATION; LIVER TOXICITY; LOOSE FECES; MUSCLE CRAMP; MUSCLE STIFFNESS; MUSCLE WEAKNESS; MYALGIA; MYOPATHY; MYOSITIS; NONHUMAN; PHYSICIAN; PUBLIC HEALTH; RHABDOMYOLYSIS; SECONDARY PREVENTION; SIDE EFFECT; STANDARDIZATION; TREATMENT DURATION; TREATMENT REFUSAL; TRIACYLGLYCEROL BLOOD LEVEL; UNSPECIFIED SIDE EFFECT;

ANIMALS; BIOLOGICAL PRODUCTS; COMPLEMENTARY THERAPIES; DIETARY SUPPLEMENTS; DRUG APPROVAL; DRUGS, CHINESE HERBAL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; LIPID METABOLISM; LIPID REGULATING AGENTS; MUSCULAR DISEASES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; TREATMENT REFUSAL;

EID: 79551529759     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-010-0145-0     Document Type: Article

References (60)

1. J Ma Y Li J Li, et al. 2000 Constituents of Red Yeast Rice, a Traditional Chinese Food and Medicine J. Agric Food Chem. 48 5220 5 1:CAS:528: DC%2BD3cXnt1SlsLo%3D 10.1021/jf000338c 11087463
2. P Van Tieghem 1884 Monascus, genre nouveau de l'ordre des Ascomycetes Bull Soc France. 31 226 31
3. FA Went 1895 Monascus purpureus le chmpignon de l'angquac une nouvelle thelobolee Ann Soc Nat Bot. 8 1 17
4. DJ Becker RY Gordon SC Halbert B French PB Morris DJ Rader 2009 Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial Ann Intern Med. 150 12 830 9 19528562 W147-9. This is the first trial evaluating red yeast rice as a lipid-lowering therapy for patients with a history of SAMs. It randomized 62 patients with a history of intolerance to one or more statins to a lifestyle-modification program and either red yeast rice or placebo and followed them for 24 weeks. The red yeast rice group had a significant decrease in LDL-C compared with placebo at 12 and 24 weeks, with no increase incidence in myalgias.
5. DJ Becker RY Gordon PB Morris, et al. 2008 Simvastatin vs therapeutic lifestyle changes and supplements: randomized primary prevention trial Mayo Clin Proc. 83 7 758 64 1:CAS:528:DC%2BD1cXovFCju70%3D 10.4065/83.7.758 18613992 This trial that randomized 74 patients to either usual therapy (simvastatin) or an alternative regimen (red yeast rice, fish oil, and a lifestyle-modification program) and followed them for 12 weeks. There were no differences between the groups in LDL-C levels and the alternative-regimen group had significant decreases in weight and triglycerides (Pubitemid 351948689)
6. Bogsrud MP, Ose L, Langslet G, et al. HypoCol (red yeast rice) lowers plasma cholesterol-a randomized placebo controlled study. Scand Cardiovasc J;44(4):197-200.
7. SC Halbert B French RY Gordon, et al. 2010 Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance Am J Cardiol 105 198 204 1:CAS:528:DC%2BC3cXosVai 10.1016/j.amjcard.2009.08.672 20102918 This is the second trial evaluating red yeast rice as an alternative lipid-lowering therapy for patients with a history of SAMs. It randomized 43 patients to red yeast rice or pravastatin and followed them for 12 weeks. There were no differences between groups in the incidence of myalgias, muscle strength, or LDL-C lowering. There was a trend toward decreased myalgias in the red yeast rice group
8. Z Lu W Kou B Du, et al. 2008 Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction Am J Cardiol. 101 12 1689 93 10.1016/j.amjcard.2008.02.056 18549841
9. CV Venero JV Venero DC Wortham PD Thompson 2010 Lipid-lowering efficacy of red yeast rice in a population intolerant to statins Am J Cardiol. 105 5 664 6 1:CAS:528:DC%2BC3cXisFemu7Y%3D 10.1016/j.amjcard.2009.10.045 20185013
10. MP McGowan S Proulx 2009 Nutritional supplements and serum lipids: does anything work? Curr Atheroscler Rep. 11 6 470 6 1:CAS:528:DC%2BC3cXhtFersrvJ 10.1007/s11883-009-0070-2 19852889
11. YG Li F Zhang ZT Wang ZB Hu 2004 Identification and chemical profiling of monacolins in red yeast rice using high-performance liquid chromatography with photodiode array detector and mass spectrometry J Pharm Biomed Anal. 35 5 1101 12 1:CAS:528:DC%2BD2cXntFSmt7k%3D 10.1016/j.jpba.2004.04.004 15336357 (Pubitemid 39140277)
12. A Endo K Monacolin 1979 a new hypocholesterolemic agent produced by a Monascus species J Antiobiot (Tokyo) 32 8 852 4 1:CAS:528:DyaE1MXmtV2htLc%3D
13. RY Gordon W Obermeyer T Cooperman DJ Becker 2010 Marked variability of monacolin levels in commercial red yeast rice products Arch Intern Med 170 19 1722 27 1:CAS:528:DC%2BC3cXhsFaitrbL 10.1001/archinternmed.2010.382 20975018
14. D Heber I Yip JM Ashley DA Elashoff RM Elashoff VL Go 1999 Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement Am J Clin Nutr. 69 2 231 6 1:CAS:528:DyaK1MXovVKitQ%3D%3D 9989685
15. CF Huang TC Li CC Lin CS Liu HC Shih MM Lai 2007 Efficacy of Monascus purpureus Went rice on lowering lipid ratios in hypercholesterolemic patients Eur J Cardiovasc Prev Rehabil. 14 3 438 40 10.1097/HJR.0b013e32801da137 17568245 (Pubitemid 46945569)
16. J Liu J Zhang Y Shi S Grimsgaard T Alraek V Fonnebo 2006 Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials Chin Med. 1 4 10.1186/1749-8546-1-4 17302963
17. JJ Li ZL Lu WR Kou, et al. 2009 Beneficial Impact of Xuezhikang on Cardiovascular Events and Mortality in Elderly Hypertensive Patients With Previous Myocardial Infarction From the China Coronary Secondary Prevention Study (CCSPS) J Clin Pharmacol. 49 8 947 956 1:CAS:528:DC%2BD1MXhtVSqur%2FK 10.1177/0091270009337509 19602720 This is the only trial that demonstrated that red yeast rice decreases cardiovascular events. Nearly 4870 Chinese patients with a history of myocardial infarction were randomized to red yeast rice or placebo and followed for 4.5 years. The red yeast group had significant decreases in overall mortality, cardiovascular mortality, and cardiovascular events compared with placebo
18. SP Zhao ZL Lu BM Du, et al. 2007 Xuezhikang, an extract of cholestin, reduces cardiovascular events in type 2 diabetes patients with coronary heart disease: subgroup analysis of patients with type 2 diabetes from China coronary secondary prevention study (CCSPS) J Cardiovasc Pharmacol. 49 2 81 4 1:CAS:528:DC%2BD2sXhvFSjtLY%3D 10.1097/FJC.0b013e31802d3a58 17312447
19. TA Jacobson 2008 Toward "pain-free" statin prescribing: clinical algorithm for diagnosis and management of myalgia Mayo Clin Proc. 83 6 687 700 10.4065/83.6.687 18533086 (Pubitemid 351810569)
20. BF Vandenberg J Robinson 2010 Management of the patient with statin intolerance Curr Atheroscler Rep. 12 1 48 57 1:CAS:528:DC%2BC3cXht1Cjs7nM 10.1007/s11883-009-0077-8 20425271
21. PD Thompson P Clarkson RH Karas 2003 Statin-associated myopathy Jama. 289 13 1681 90 1:CAS:528:DC%2BD3sXisF2is7k%3D 10.1001/jama.289.13.1681 12672737 (Pubitemid 37430274)
22. A Kashani CO Phillips JM Foody, et al. 2006 Risks associated with statin therapy: a systematic overview of randomized clinical trials Circulation. 114 25 2788 97 1:CAS:528:DC%2BD28Xht12ktbjI 10.1161/CIRCULATIONAHA.106.624890 17159064 (Pubitemid 46018281)
23. M Mitka 2003 Expanding statin use to help more at-risk patients is causing financial heartburn Jama. 290 17 2243 5 1:CAS:528:DC%2BD3sXovVeqtbk%3D 10.1001/jama.290.17.2243 14600168 (Pubitemid 37430551)
24. KE Hansen JP Hildebrand EE Ferguson JH Stein 2005 Outcomes in 45 patients with statin-associated myopathy Arch Intern Med. 165 22 2671 6 10.1001/archinte.165.22.2671 16344427 (Pubitemid 41785067)
25. R Cartin-Ceba LB Lu A Kolpakchi 2007 A 'natural' threat Am J Med. 120 11 e3 4 10.1016/j.amjmed.2007.04.018 17976405 (Pubitemid 47633478)
26. PS Mueller 2006 Symptomatic myopathy due to red yeast rice Ann Intern Med. 145 6 474 5 16983142
27. DJ Smith KE Olive 2003 Chinese red rice-induced myopathy South Med J. 96 12 1265 7 10.1097/01.SMJ.0000100117.79718.DC 14696880 (Pubitemid 38090587)
28. L Vercelli T Mongini N Olivero C Rodolico O Musumeci L Palmucci 2006 Chinese red rice depletes muscle coenzyme Q10 and maintains muscle damage after discontinuation of statin treatment J Am Geriatr Soc. 54 4 718 20 10.1111/j.1532-5415.2006.00668-7.x 16686894
29. Lapi F, Gallo E, Bernasconi S, et al. Myopathies associated with red yeast rice and liquorice: spontaneous reports from the Italian Surveillance System of Natural Health Products. Br J Clin Pharmacol. 2008.
30. H Roselle A Ekatan J Tzeng M Sapienza J Kocher 2008 Symptomatic hepatitis associated with the use of herbal red yeast rice Ann Intern Med. 149 7 516 7 18838736
31. W Wigger-Alberti A Bauer UC Hipler P Elsner 1999 Anaphylaxis due to Monascus purpureus-fermented rice (red yeast rice) Allergy. 54 12 1330 1 1:STN:280:DC%2BD3c7ltFWnuw%3D%3D 10.1034/j.1398-9995.1999.00374.x 10688441 (Pubitemid 30070326)
32. D Heber A Lembertas QY Lu S Bowerman VL Go 2001 An analysis of nine proprietary Chinese red yeast rice dietary supplements: implications of variability in chemical profile and contents J Altern Complement Med. 7 2 133 9 1:STN:280:DC%2BD3MvntlGqtg%3D%3D 10.1089/107555301750164181 11327519
33. Weiss R. Tainted Chinese Exports Common. Washington Post. May 20, 2007; http://www.washingtonpost.com/wp-dyn/content/article/2007/05/19/AR2007051901273. html. Accessed September 17, 2010.
34. A Endo M Kuroda 1976 Citrinin, an inhibitor of cholesterol synthesis J Antibiot (Tokyo). 29 8 841 3 1:CAS:528:DyaE28XltFKktr0%3D
35. JW Bennett M Klich 2003 Mycotoxins Clin Microbiol Rev. 16 3 497 516 1:CAS:528:DC%2BD3sXmsV2qtL4%3D 10.1128/CMR.16.3.497-516.2003 12857779 (Pubitemid 36871318)
36. RJ Havel 1999 Dietary supplement or drug? The case of cholestin Am J Clin Nutr. 69 2 175 6 1:CAS:528:DyaK1MXovVKjuw%3D%3D 9989677
37. Miller SJ. Letter to Dirk Reischig, Nature's Way Products, Inc. January 25, 2008. http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2008/ ucm1048419.htm. Accessed September 18, 2010.
38. Kimpel P. The Cholestin Case: Drugs vs. Supplements. http://iml.jou.ufl. edu/projects/Spring2000/Kimpel/cholestin.html. Accessed September 18, 2010.
39. Moore RJ. Letter to Sonia Rodriguez, Mason Vitamins. May 5, 2001. http://www.fda.gov/OHRMS/DOCKETS/dailys/01/Jun01/061101/let0494.pdf. Accessed September 18, 2010.
40. T Lee 2009 Ask the doctor. What is the story on using red yeast rice to lower cholesterol? You have warned readers against using it in the past, but I heard about a new study that shows it works. Are you ready to admit you are wrong on this one? Harv Heart Lett 20 4 8
41. PS Phillips 2009 Balancing randomized trials with anecdote Ann Intern Med. 150 12 885 6 19528568
42. M Carter JH O'Keefe DJ Becker RY Gordon J Gordon 2008 Is red yeast rice a suitable alternative for statins? Mayo Clin Proc. 83 11 1294 10.4065/83.11.1294 18990329 author reply 1294-6
43. TR Joy RA Hegele 2009 Narrative review: statin-related myopathy Ann Intern Med. 150 12 858 68 19528564
44. Stengler MA. Are Statin Drugs Destroying Your Muscles? http://www.bottomlinesecrets.com/article.html?article-id=100000937. 2010:Accessed September 13, 2010.
45. BG Brown XQ Zhao A Chait, et al. 2001 Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease N Engl J Med. 345 22 1583 92 1:CAS:528:DC%2BD3MXoslyhsLs%3D 10.1056/NEJMoa011090 11757504 (Pubitemid 33126837)
46. PN Durrington D Bhatnagar MI Mackness, et al. 2001 An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia Heart. 85 5 544 8 1:STN:280: DC%2BD3M3ms1SqtA%3D%3D 10.1136/heart.85.5.544 11303007
47. AC Goldberg RE Ostlund Jr JH Bateman L Schimmoeller TB McPherson CA Spilburg 2006 Effect of plant stanol tablets on low-density lipoprotein cholesterol lowering in patients on statin drugs Am J Cardiol. 97 3 376 9 1:CAS:528:DC%2BD28Xos1WisA%3D%3D 10.1016/j.amjcard.2005.08.056 16442399 (Pubitemid 43133053)
48. SA Siddiqi PD Thompson 2009 How do you treat patients with myalgia who take statins? Curr Atheroscler Rep. 11 1 9 14 1:CAS:528:DC%2BD1MXltVSks7k%3D 10.1007/s11883-009-0002-1 19080722
49. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama. 2001;285(19):2486-97
50. L Marcoff PD Thompson 2007 The role of coenzyme Q10 in statin-associated myopathy: a systematic review J Am Coll Cardiol. 49 23 2231 7 1:CAS:528:DC%2BD2sXmtlWisrg%3D 10.1016/j.jacc.2007.02.049 17560286 (Pubitemid 46856819)
51. JH Lee JH O'Keefe D Bell DD Hensrud MF Holick 2008 Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol. 52 24 1949 56 1:CAS:528:DC%2BD1cXhsVKlsLzF 10.1016/j.jacc.2008.08.050 19055985
52. AE Moreyra AC Wilson A Koraym 2005 Effect of combining psyllium fiber with simvastatin in lowering cholesterol Arch Intern Med. 165 10 1161 6 1:CAS:528:DC%2BD2MXlsFaju7s%3D 10.1001/archinte.165.10.1161 15911730 (Pubitemid 40720741)
53. IF Gazi SS Daskalopoulou DR Nair DP Mikhailidis 2007 Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin Curr Med Res Opin. 23 9 2183 92 1:CAS:528:DC%2BD2sXht12rtL%2FF 10.1185/030079907X226267 17692154 (Pubitemid 350246604)
54. EA Stein CM Ballantyne E Windler, et al. 2008 Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins Am J Cardiol. 101 4 490 6 1:CAS:528: DC%2BD1cXhslektL8%3D 10.1016/j.amjcard.2007.09.099 18312764 (Pubitemid 351199443)
55. CJ Glueck D Aregawi M Agloria, et al. 2006 Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies Clin Ther. 28 6 933 42 1:CAS:528:DC%2BD28Xot1aiurg%3D 10.1016/j.clinthera.2006.06.004 16860175 (Pubitemid 44062693)
56. JM Backes PM Moriarty JF Ruisinger CA Gibson 2007 Effects of once weekly rosuvastatin among patients with a prior statin intolerance Am J Cardiol. 100 3 554 5 1:CAS:528:DC%2BD2sXot1ymu7o%3D 10.1016/j.amjcard.2007.03.059 17659946 (Pubitemid 47096826)
57. M Gadarla AK Kearns PD Thompson 2008 Efficacy of rosuvastatin (5 mg and 10 mg) twice a week in patients intolerant to daily statins Am J Cardiol. 101 12 1747 8 1:CAS:528:DC%2BD1cXnt1SltbY%3D 10.1016/j.amjcard.2008.02.061 18549851
58. JM Backes CV Venero CA Gibson, et al. 2008 Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance Ann Pharmacother. 42 3 341 6 1:CAS:528:DC%2BD1cXktlalsr8%3D 10.1345/aph.1K604 18285559 (Pubitemid 351429598)
59. MA Juszczyk RL Seip PD Thompson 2005 Decreasing LDL cholesterol and medication cost with every-other-day statin therapy Prev Cardiol. 8 4 197 9 10.1111/j.0197-3118.2005.04404.x 16230873
60. SM Rivers MP Kane RS Busch G Bakst RA Hamilton 2007 Colesevelam hydrochloride-ezetimibe combination lipid-lowering therapy in patients with diabetes or metabolic syndrome and a history of statin intolerance Endocr Pract. 13 1 11 6 17360295